Funding
← Back to your selection

IQ Capital

Activity from announced rounds

Activity in this selectionOct 17, 2026 · Jul 20, 2026
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$48M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Series A1

By primary sector

Biotech1
Cybersecurity1

By country

United Kingdom2

Rounds

2 in this selection
Undecimal Bio

Undecimal Bio develops delivery molecules that help RNA medicines reach specific tissues, with initial research programmes in kidney and vascular disease.

$18MSeed
Lead
Mindgard

Mindgard helps enterprise security teams find and address vulnerabilities in AI models, applications and agents.

$30MSeries A
Participant